Metformin: Is it a drug for all reasons and diseases?
<p>Metformin was first used to treat type 2 diabetes in the late 1950s and in 2022 remains the first-choice drug used daily by approximately 150 million people. An accumulation of positive pre-clinical and clinical data has stimulated interest in re-purposing metformin to treat a variety of di...
محفوظ في:
| المؤلف الرئيسي: | Chris R. Triggle (4278688) (author) |
|---|---|
| مؤلفون آخرون: | Ibrahim Mohammed (4091773) (author), Khalifa Bshesh (14683600) (author), Isra Marei (11312895) (author), Kevin Ye (7484105) (author), Hong Ding (135247) (author), Ross MacDonald (3496682) (author), Morley D. Hollenberg (11679217) (author), Michael A. Hill (8766807) (author) |
| منشور في: |
2022
|
| الموضوعات: | |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Metformin and HER2-positive breast cancer: Mechanisms and therapeutic implications
حسب: Sara S Bashraheel (17807612)
منشور في: (2023) -
Metabolic heterogeneity in TNBCs: A potential determinant of therapeutic efficacy of 2-deoxyglucose and metformin combinatory therapy
حسب: Samson Mathews Samuel (11008848)
منشور في: (2023) -
Osmolar-gap in the setting of metformin-associated lactic acidosis
حسب: Mohamed Nabil Elshafei (9960500)
منشور في: (2020) -
Counteracting Chemoresistance with Metformin in Breast Cancers: Targeting Cancer Stem Cells
حسب: Samson Mathews Samuel (11008848)
منشور في: (2020) -
Metformin: The Answer to Cancer in a Flower? Current Knowledge and Future Prospects of Metformin as an Anti-Cancer Agent in Breast Cancer
حسب: Samson Samuel (6828956)
منشور في: (2019)